Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1995-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00169328PMID 7539523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.

  2009cited by this paper
• Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides

  2005cited by this paper
• Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393

  2004cited by this paper
• The motor effects of bromocriptine — a review

  2004cited by this paper
• Dopamine receptor pharmacology.

  1993cited by this paper
• Are neostriatal dopamine receptors co-localized?

  1993cited by this paper
• Effects produced by acute and chronic treatment with granisetron alone or in combination with haloperidol on midbrain dopamine neurons.

  1992cited by this paper
• 5-HT receptors: subtypes and second messengers.

  1991cited by this paper
• Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.

  1991cited by this paper
• Photocell measurements of rat motor activity. A contribution to sensitivity and variation in behavioral observations.

  1991cited by this paper
• The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.

  1991cited by this paper
• Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.

  1991cited by this paper
• Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons.

  1990cited by this paper
• Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine

  1990influential reference
• Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons.

  1989cited by this paper
• Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function

  1989cited by this paper
• Dopamine‐mediated behaviours produced in naive mice by bromocriptine plus SKF 38393

  1988cited by this paper
• Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.

  1988cited by this paper
• Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor.

  1988cited by this paper
• Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons.

  1987cited by this paper
• Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex.

  1986cited by this paper
• Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.

  1986cited by this paper
• Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.

  1986cited by this paper
• Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice

  1985cited by this paper
• Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain.

  1985cited by this paper
• Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.

  1985cited by this paper
• Behavioral correlations of dopamine receptor activation

  1983cited by this paper
• Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.

  1983cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper
• Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats.

  1982cited by this paper
• Inhibition of neurotransmitter receptor binding by ergot derivatives

  1981cited by this paper
• Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.

  1981cited by this paper
• Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum

  1981cited by this paper
• Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat.

  1980cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography--electrochemical detection system.

  1980cited by this paper
• Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles.

  1980cited by this paper
• Evidence for an irreversible interaction of bromocryptine with central dopamine receptors

  1980cited by this paper
• Evidence for in vivo binding of apomorphine and bromocriptine to receptor sites not labelled by 3H-spiperone.

  1979cited by this paper
• A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

  1978cited by this paper
• Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

  1978cited by this paper
• Bromocriptine, lergotrile: the antiparkinsonian efficacy and the interaction with monoaminergic receptors.

  1978cited by this paper
• Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.

  1978cited by this paper
• 3H-Spiroperidol labels dopamine receptors in pituitary and brain.

  1977cited by this paper
• Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.

  1977cited by this paper

• Copulation is reactivated by bromocriptine in male rats after reaching sexual satiety with a same sexual mate.

  2015cites this paper
• Fos expression in response to dopamine D3‐preferring phenylpiperazine drugs given with and without cocaine

  2013cites this paper
• Hyperprolactinemia impairs object recognition without altering spatial learning in male rats.

  2013cites this paper
• Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice

  2010cites this paper
• The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the alpha2-adrenergic receptors in beta cells.

  2010cites this paper
• Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine

  2009cites this paper
• Lack of effect of Nω‐nitro‐L‐arginine methyl ester on bromocriptine‐induced locomotor sensitization in mice

  2007cites this paper
• A review of pharmacological treatments used in experimental models of traumatic brain injury

  2007cites this paper
• Chronic treatment with bromocriptine modifies metabolic adjustments in response to restraint stress in rats.

  2007cites this paper
• Caffeine and activation theory : effects on health and behavior

  2006cites this paper
• Pharmacological Properties and Neurophsysiological Effects of Caffeine

  2006cites this paper
• Attenuation of Working Memory and Spatial Acquisition Deficits after a Delayed and Chronic Bromocriptine Treatment Regimen in Rats Subjected to Traumatic Brain Injury by Controlled Cortical Impact

  2002cites this paper
• Modulation of Monoaminergic Neural Circuits

  2002cites this paper
• Modulation of monoaminergic neural circuits: potential for the treatment of type 2 diabetes mellitus.

  2002cites this paper
• Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect.

  2002cites this paper
• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. III. Agonist and Antagonist Properties at Serotonin, 5-HT1 and 5-HT2, Receptor Subtypes

  2002cites this paper
• Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

  2002cites this paper
• Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?

  2001cites this paper
• Atropisomeric derivatives of 2',6'-disubstituted (R)-11-phenylaporphine: selective serotonin 5-HT(7) receptor antagonists.

  2001cites this paper
• ASSOCIATION OF THE ANTIDIABETIC EFFECTS OF BROMOCRIPTINE WITH A SHIFT IN THE DAILY RHYTHM OF MONOAMINE METABOLISM WITHIN THE SUPRACHIASMATIC NUCLEI OF THE SYRIAN HAMSTER

  2000cites this paper
• Psychomotor-activating effects mediated by dopamine D(2) and D(3) receptors in the nucleus accumbens.

  2000cites this paper
• Derivatives of (R)-1,11-methyleneaporphine: synthesis, structure, and interactions with G-protein coupled receptors.

  2000cites this paper
• Novel derivatives of 3-(dipropylamino)chroman. Interactions with 5-HT1A and D2A receptors.

  1999cites this paper
• Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.

  1999cites this paper
• Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice.

  1999cites this paper
• Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization.

  1998cites this paper
• Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease.

  1998cites this paper
• (R)-(+)-2-[[[3-(Morpholinomethyl)-2H-chromen-8-yl]oxy]methyl] morpholine methanesulfonate: a new selective rat 5-hydroxytryptamine1B receptor antagonist.

  1998cites this paper
• Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.

  1996cites this paper